These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 361347)

  • 1. Effect on platelet adhesiveness in diabetics after long-term treatment with a new oral hypoglycaemic agent, gliclazide.
    Rubinjoni Z; Turk Z; Coce F; Mustovic D; Maitre D; Skrabalo Z
    Curr Med Res Opin; 1978; 5(8):625-31. PubMed ID: 361347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gliclazide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus.
    Holmes B; Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1984 Apr; 27(4):301-27. PubMed ID: 6373223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of diet and gliclazide on the haemostatic system of non-insulin-dependent diabetics.
    Paton RC; Kernoff PB; Wales JK; McNicol GP
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1018-20. PubMed ID: 6794745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of weight gain with gliclazide treatment for 30 months in type II diabetes.
    Robb GH; Lowe SM
    Curr Med Res Opin; 1984; 9(1):7-9. PubMed ID: 6723350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is sulphonylurea therapy effective long term? A 3-year study with gliclazide.
    Zurro Hernandez J; Lavielle R
    Curr Med Res Opin; 1986; 10(5):351-8. PubMed ID: 3816294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-platelet effects of long-term treatment with gliclazide in diabetic patients.
    Ponari O; Civardi E; Megha S; Pini M; Portioli D; Dettori AG
    Thromb Res; 1979; 16(1-2):191-203. PubMed ID: 116387
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of gliclazide and glibenclamide treatment in non-insulin-dependent diabetes.
    Baba S; Nakagawa S; Takebe K; Goto Y; Maezawa H; Takeda R; Sakamoto N; Fukui I
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():693-706. PubMed ID: 6440313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of gliclazide on platelet behavior].
    Verry M; Dechavanne M; Desnoyers P; Stoltz JF; Vainer H
    Nouv Presse Med; 1974 Oct; 3(33):2099-100. PubMed ID: 4471584
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of treatment with metformin and gliclazide in patients with non-insulin-dependent diabetes.
    McAlpine LG; McAlpine CH; Waclawski ER; Storer AM; Kay JW; Frier BM
    Eur J Clin Pharmacol; 1988; 34(2):129-32. PubMed ID: 3289948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients.
    Collier A; Watson HH; Patrick AW; Ludlam CA; Clarke BF
    Diabete Metab; 1989; 15(6):420-5. PubMed ID: 2534084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medium term effect (3 months) of hypoglycemic sulfamide treatment (gliclazide) on insulin secretion of the non-insulin dependent diabetic].
    Brogard JM; Pinget M; Leconte A; Dorner M
    Rev Med Interne; 1982 Dec; 3(4):379-87. PubMed ID: 6761818
    [No Abstract]   [Full Text] [Related]  

  • 12. Preventive and therapeutic effects of gliclazide on diabetic retinopathy: comparison with glibenclamide treatment.
    Minami N; Ikeda Y; Abe M
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():707-11. PubMed ID: 6440314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypoglycemic and microvascular properties of gliclazide: a review of the latest international studies].
    Lesobre B
    Sem Hop; 1983 Jun; 59(24):1827-33. PubMed ID: 6308816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the sulphonylurea drugs gliclazide and glibenclamide on blood glucose control and platelet function.
    Klaff LJ; Vinik AI; Jackson WP; Malan E; Kernoff L; Jacobs P
    S Afr Med J; 1979 Aug; 56(7):247-50. PubMed ID: 121645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic value of a new oral antidiabetic agent: gliclazide].
    Bernasconi D; Mazzi C
    Clin Ter; 1978 Mar; 84(6):627-35. PubMed ID: 648108
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gliclazide in the non-insulin-dependent diabetic patient in geriatrics].
    Frühwald T; Böhmer F
    Wien Med Wochenschr; 1988 Mar; 138(5):102-6. PubMed ID: 3388872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Survey of 832 case records of diabetes of adult onset treated by Diamicron. Evolution of metabolism and weight].
    Estivals JP; Giraudet MC; Videau JY
    Journ Annu Diabetol Hotel Dieu; 1978; ():333-40. PubMed ID: 349228
    [No Abstract]   [Full Text] [Related]  

  • 18. Gliclazide in the treatment of obese non-insulin dependent diabetic patients.
    Seshiah V; Venkataraman S; Suresh K
    J Assoc Physicians India; 1993 Jun; 41(6):367-8. PubMed ID: 8005974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term ambulatory treatment of diabetics with gliclazide].
    Parodi FA
    Clin Ter; 1979 Feb; 88(3):281-8. PubMed ID: 376219
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of effect of gliclazide on platelet aggregation in insulin-treated and non-insulin-treated diabetes: a two-year controlled study.
    Larkins RG; Jerums G; Taft JL; Godfrey H; Smith IL; Martin TJ
    Diabetes Res Clin Pract; 1988 Jan; 4(2):81-7. PubMed ID: 3125029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.